Status gelasticus after temporal lobectomy: ictal FDG-PET findings and the question of dual pathology involving hypothalamic hamartomas

Epilepsia. 2005 Aug;46(8):1313-6. doi: 10.1111/j.1528-1167.2005.52804.x.

Abstract

Purpose: To present the first ictal fluorodeoxyglucose-positron emission tomography (FDG-PET) evidence of the hypothalamic origin of gelastic seizures in a patient with a hypothalamic hamartoma (HH) and to raise the issue of true dual pathology related to this entity.

Methods: Ictal FDG-PET was acquired during an episode of status gelasticus with preserved consciousness, in a patient previously operated on for complex partial seizures (CPSs) due to a temporal lobe epileptogenic cyst.

Results: Ictal hypermetabolism was localized to the region of the HH during the status gelasticus. CPSs had been completely eliminated after temporal lobe surgery.

Conclusions: Ictal FDG-PET independently confirmed that gelastic seizures in patients with HH do originate in the diencephalic lesion. An HH may coexist with another epileptogenic lesion, in a context of dual pathology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anterior Temporal Lobectomy
  • Arachnoid Cysts / epidemiology
  • Arachnoid Cysts / surgery
  • Comorbidity
  • Epilepsies, Partial / diagnostic imaging*
  • Epilepsies, Partial / etiology
  • Epilepsy, Complex Partial / surgery
  • Epilepsy, Temporal Lobe / epidemiology
  • Epilepsy, Temporal Lobe / pathology
  • Epilepsy, Temporal Lobe / surgery*
  • Fluorodeoxyglucose F18
  • Hamartoma / diagnostic imaging
  • Hamartoma / epidemiology
  • Hamartoma / pathology
  • Hamartoma / surgery*
  • Humans
  • Hypothalamic Diseases / epidemiology
  • Hypothalamic Diseases / pathology
  • Hypothalamic Diseases / surgery*
  • Magnetic Resonance Imaging
  • Male
  • Positron-Emission Tomography*
  • Postoperative Complications / diagnostic imaging*
  • Postoperative Complications / etiology
  • Temporal Lobe / diagnostic imaging
  • Temporal Lobe / pathology
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Substances

  • Fluorodeoxyglucose F18